8 Matching Annotations
  1. Aug 2022
  2. www.nytimes.com www.nytimes.com
    An extra J. & J. shot substantially boosts protection against Covid, the company reports.
    1
    1. jackiekrauss 29 Aug 2022

      Zimmer, C. (2021, September 21). An extra J. & J. shot substantially boosts protection against Covid, the company reports. The New York Times. https://www.nytimes.com/2021/09/21/health/johnson-and-johnson-shot.html

      is:news lang:en Johnson & Johnson vaccine second dose 94 percent efficacy emergency use authorization Pfizer-BioNTech booster waning antibody level
    Visit annotations in context

    Tags

    Annotators

    URL

    nytimes.com/2021/09/21/health/johnson-and-johnson-shot.html
  3. twitter.com twitter.com
    Natalie E. Dean, PhD on Twitter
    1
    1. jackiekrauss 29 Aug 2022

      Dean, N. E. (2021, September 21). Hmm okay. J&J two dose results are a bit more complicated, with different results globally versus within the US. https://t.co/prFUorU8LE [Tweet]. @nataliexdean. https://twitter.com/nataliexdean/status/1440318770665324560

      is:tweet lang:en Johnson & Johnson second dose global result US result protection booster antibody level
    Visit annotations in context

    Tags

    Annotators

    URL

    twitter.com/nataliexdean/status/1440318770665324560
  4. www.theguardian.com www.theguardian.com
    Long Covid: doctors find ‘antibody signature’ for patients most at risk
    1
    1. jackiekrauss 29 Aug 2022

      Sample, I. (2022, January 25). Long Covid: Doctors find ‘antibody signature’ for patients most at risk. The Guardian. https://www.theguardian.com/society/2022/jan/25/doctors-find-antibody-signature-long-covid

      is:news lang:en COVID-19 long COVID-19 antibody signature low level debilitating symptom prediction long-term illness immunoglobulin signature increased risk IgM IgG3
    Visit annotations in context

    Tags

    Annotators

    URL

    theguardian.com/society/2022/jan/25/doctors-find-antibody-signature-long-covid
  5. Oct 2021
  6. www.bmj.com www.bmj.com
    Covid-19: Just a third of blood cancer patients had antibodies against delta variant after two vaccine doses, study finds
    1
    1. Marlene_Wulf 31 Oct 2021

      Mahase, E. (2021). Covid-19: Just a third of blood cancer patients had antibodies against delta variant after two vaccine doses, study finds. BMJ, 375, n2623. https://doi.org/10.1136/bmj.n2623

      is:article lang:en COVID-19 blood cancer patient antibody Delta variant two vaccine doses study lower level neutralising
    Visit annotations in context

    Tags

    Annotators

    URL

    bmj.com/content/375/bmj.n2623
  7. Sep 2021
  8. www.newscientist.com www.newscientist.com
    Blood test could reveal who is most likely to get severe covid-19
    1
    1. jackiekrauss 14 Sep 2021

      Wilson, C. (2021, September 9). Blood test could reveal who is most likely to get severe covid-19. New Scientist. https://www.newscientist.com/article/2289718-blood-test-could-reveal-who-is-most-likely-to-get-severe-covid-19/

      is:news lang:en COVID-19 blood test symptom severity ventilator antibody level DNA phosphatidylserine deterioration red blood cell immune cell treatment
    Visit annotations in context

    Tags

    Annotators

    URL

    newscientist.com/article/2289718-blood-test-could-reveal-who-is-most-likely-to-get-severe-covid-19/
  9. Aug 2021
  10. www.theguardian.com www.theguardian.com
    We shouldn’t be giving Covid boosters while millions wait for a first dose | Andrew Pollard and Seth Berkley
    1
    1. lucyparfitt16 17 Aug 2021

      We shouldn’t be giving Covid boosters while millions wait for a first dose | Andrew Pollard and Seth Berkley | The Guardian. (n.d.). Retrieved August 17, 2021, from https://www.theguardian.com/commentisfree/2021/aug/13/covid-boosters-dose-vaccine

      is:webpage lang:en COVID-19 vaccine booster risk mortality government booster dose science antibody level epidemiology immunity protection variant data analysis help aid
    Visit annotations in context

    Tags

    Annotators

    URL

    theguardian.com/commentisfree/2021/aug/13/covid-boosters-dose-vaccine
  11. www.thelancet.com www.thelancet.com
    Spike-antibody waning after second dose of BNT162b2 or ChAdOx1
    1
    1. lucyparfitt16 04 Aug 2021

      Shrotri, M., Navaratnam, A. M. D., Nguyen, V., Byrne, T., Geismar, C., Fragaszy, E., Beale, S., Fong, W. L. E., Patel, P., Kovar, J., Hayward, A. C., & Aldridge, R. W. (2021). Spike-antibody waning after second dose of BNT162b2 or ChAdOx1. The Lancet, 398(10298), 385–387. https://doi.org/10.1016/S0140-6736(21)01642-1

      is:article lang:en COVID-19 vaccine transmission morbidity mortality vaccine efficacy immunogenicity spike protein antibody level dose research science variant immunity booster UK
    Visit annotations in context

    Tags

    Annotators

    URL

    thelancet.com/journals/lancet/article/PIIS0140-6736(21)01642-1/fulltext
  12. Aug 2020
  13. www.medrxiv.org www.medrxiv.org
    https://doi.org/10.1101/2020.07.08.20148353
    1
    1. ErikStuchly 28 Aug 2020

      Consiglio, C. R., Cotugno, N., Sardh, F., Pou, C., Amodio, D., Zicari, S., Ruggiero, A., Pascucci, G. R., Rodriguez, L., Santilli, V., Tan, Z., Eriksson, D., Wang, J., Lakshmikanth, T., Marchesi, A., Lakshmikanth, T., Campana, A., Villani, A., Rossi, P., … Brodin, P. (2020). The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. MedRxiv, 2020.07.08.20148353. https://doi.org/10.1101/2020.07.08.20148353

      is:preprint lang:en COVID-19 immunology multisystem inflammatory syndrome children asymptomatic infection symptom systems-level analysis immunity antibody arterial damage pathogenesis candidate
    Visit annotations in context

    Tags

    Annotators

    URL

    medrxiv.org/cgi/content/10.1101/2020.07.08.20148353